✦ LIBER ✦

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site : A Minnie Pearl Cancer Research Network Phase II trial

✍ Scribed by John D. Hainsworth; David R. Spigel; Eric L. Raefsky; Michel E. Kuzur; Kathleen Yost; Michael Kommor; Sharlene Litchy; F. Anthony Greco

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 88 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of carboplatin, gemcitabi

Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site

✍ Bryan J. Schneider; Basil El-Rayes; Jeffery H. Muler; Philip A. Philip; Gregory 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven

A randomized Phase II trial in patients

A randomized Phase II trial in patients with carcinoma of an unknown primary site

✍ Jonathan E. Dowell; Audrey M. Garrett; Yu Shyr; David H. Johnson; Kenneth R. Han 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Gemcitabine and vinorelbine in the secon

Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients : A Minnie Pearl Cancer Research Network Phase II trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Joan B. Erland; Jerem 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## BACKGROUND. Second-line chemotherapy for patients with nonsmall cell lung carcinoma has been ineffective due to the lack of activity of older agents following platinum-based therapy. This Phase II trial evaluated the feasibility, toxicity, and efficacy of two active new agents, gemcitabine and v

Paclitaxel, carboplatin, and gemcitabine

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium : A Phase II trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Anthony A. Meluch; Sharlene Litchy; Frederick M. Schnell; Ja 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Weekly combination chemotherapy with doc

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Donna Carrell; Ronald L. Drengler; Carroll Scroggin Jr.; F. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract ## BACKGROUND The goal of the current study was to evaluate the feasibility, toxicity, and efficacy of a novel combination of weekly docetaxel and gemcitabine for elderly patients and patients with poor performance status who had advanced‐stage small cell lung carcinoma (SCLC). ## MET

Weekly docetaxel in the treatment of eld

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Lisa H. Morrissey; Jo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Background: Weekly administration of docetaxel was found to reduce myelosuppression and other nonhematologic toxicities when compared with administration every 3 weeks. in the current phase ii trial, the authors evaluated the feasibility, toxicity, and efficacy of weekly docetaxel in the treatme